# Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration

> **NCT04241536** · NA · COMPLETED · sponsor: **Association for Innovation and Biomedical Research on Light and Image** · enrollment: 295 (actual)

## Conditions studied

- Age-related Macular Degeneration

## Interventions

- **PROCEDURE:** Blood draw and urine collection

## Key facts

- **NCT ID:** NCT04241536
- **Lead sponsor:** Association for Innovation and Biomedical Research on Light and Image
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-11-29
- **Final completion:** 2022-11-29
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2023-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04241536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04241536, "Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04241536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*